Latest filing published 15 Sept 2026 for Neurocrine Biosciences INC. Read the official filing
No signal scores available.
Sanjay Chandru Keswani is a declared insider of Neurocrine Biosciences Inc, with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated 11 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 15 September 2026, reports a share grant in Neurocrine Biosciences Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations